Cited by 203Cannabis and Cannabinoid ResearchSchizophrenia research and treatmentPsychedelics and Drug Studies

The DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.

Induction of Psychosis byΔ9-Tetrahydrocannabinol Reflects Modulation of Prefrontal and Striatal Function During Attentional Salience Processing

Bhattacharyya, Sagnik·2012·Archives of General Psychiatry

DOI 10.1001/archgenpsychiatry.2011.161

Open this paper in CoChat — free account

Abstract

CONTEXT: The aberrant processing of salience is thought to be a fundamental factor underlying psychosis. Cannabis can induce acute psychotic symptoms, and its chronic use may increase the risk of schizophrenia. We investigated whether its psychotic effects are mediated through an influence on attentional salience processing. OBJECTIVE: To examine the effects of Δ9-tetrahydrocannabinol (Δ9-THC) and cannabidiol (CBD) on regional brain function during salience processing. DESIGN: Volunteers were studied using event-related functional magnetic resonance imaging on 3 occasions after administration of Δ9-THC, CBD, or placebo while performing a visual oddball detection paradigm that involved allocation of attention to infrequent (oddball) stimuli within a string of frequent (standard) stimuli. SETTING: University center. PARTICIPANTS: Fifteen healthy men with minimal previous cannabis use. MAIN OUTCOME MEASURES: Symptom ratings, task performance, and regional brain activation. RESULTS: During the processing of oddball stimuli, relative to placebo, Δ9-THC attenuated activation in the right caudate but augmented it in the right prefrontal cortex. Δ9-Tetrahydrocannabinol also reduced the response latency to standard relative to oddball stimuli. The effect of Δ9-THC in the right caudate was negatively correlated with the severity of the psychotic symptoms it induced and its effect on response latency. The effects of CBD on task-related activation were in the opposite direction of those of Δ9-THC; relative to placebo, CBD augmented left caudate and hippocampal activation but attenuated right prefrontal activation. CONCLUSIONS: Δ9-Tetrahydrocannabinol and CBD differentially modulate prefrontal, striatal, and hippocampal function during attentional salience processing. These effects may contribute to the effects of cannabis on psychotic symptoms and on the risk of psychotic disorders.

Integrity signals

Registry

Crossref · 10.1001/archgenpsychiatry.2011.161

Cites

73 of 73 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

The Positive and Negative Syndrome Scale (PANSS) for schizophrenia.
Kay, S. R., Fiszbein, A., & Opler, L. A. (1987) · Schizophrenia Bulletin · doi:10.1093/schbul/13.2.261 · Cited by 21,378
Co-Planar Stereotaxic Atlas of the Human Brain
Talairach, J., & Tournoux, P. (1988) · Medical Entomology and Zoology · Cited by 11,798
Dissociable intrinsic connectivity networks for salience processing and executive control
Seeley, W. W., Menon, V., Schatzberg, A. F., Keller, J., Glover, G. H., Kenna, H., Reiss, A. L., & Greicius, M. D. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.5587-06.2007 · Cited by 7,426
Psychosis as a state of aberrant salience: a framework linking biology, phenomenology and pharmacology in schizophrenia
Kapur, S. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.1.13 · Cited by 2,813
The Dopamine Hypothesis of Schizophrenia: Version III--The Final Common Pathway
Howes, O. D., & Kapur, S. (2009) · Schizophrenia Bulletin · doi:10.1093/schbul/sbp006 · Cited by 2,693
The debate over dopamine’s role in reward: the case for incentive salience
Berridge, K. C. (2007) · Psychopharmacology · doi:10.1007/s00213-006-0578-x · Cited by 2,347
Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review.
Moore, T. H., Zammit, S., Lingford-Hughes, A., Barnes, T. R., Jones, P. B., Burke, M., & Lewis, G. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61162-3 · Cited by 2,224
The diverse CB 1 and CB 2 receptor pharmacology of three plant cannabinoids: Δ 9 ‐tetrahydrocannabinol, cannabidiol and Δ 9 ‐tetrahydrocannabivarin
Pertwee, R. G. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707442 · Cited by 2,047
The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: Implications for psychosis
D'Souza, D. C., Perry, E., MacDougall, L., Ammerman, Y., Cooper, T., Wu, Y.-T., Braley, G., Gueorguieva, R., & Krystal, J. H. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300496 · Cited by 1,024
Endogenous Potentials Generated in the Human Hippocampal Formation and Amygdala by Infrequent Events
Halgren, E., Squires, N. K., Wilson, C. L., Rohrbaugh, J., Babb, T. L., & Crandall, P. H. (1980) · Science · doi:10.1126/science.7434000 · Cited by 778

Show all 73 references

Sorted by citations

Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders
Campos, A. C., Moreira, F. A., Gomes, F. V., Del Bel, E. A., & Guimarães, F. S. (2012) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2011.0389 · Cited by 475
Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment
Englund, A., Morrison, P. D., Nottage, J. F., Hague, D., Kane, F., Bonaccorso, S., Stone, J. M., Reichenberg, A., Brenneisen, R., Holt, D., et al. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881112460109 · Cited by 479
Structural and Functional Imaging Studies in Chronic Cannabis Users: A Systematic Review of Adolescent and Adult Findings
Batalla, A., Bhattacharyya, S., Yücel, M., Fusar‐Poli, P., Crippa, J. A. S., Nogué, S., Torrens, M., Pujol, J., Farré, M., & Martín‐Santos, R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055821 · Cited by 437
Self-citation
Cannabidiol for the Reduction of Cue-Induced Craving and Anxiety in Drug-Abstinent Individuals With Heroin Use Disorder: A Double-Blind Randomized Placebo-Controlled Trial
Hurd, Y. L., Spriggs, S. A., Alishayev, J., Winkel, G. H., Gurgov, K., Kudrich, C., Oprescu, A. M., & Salsitz, E. A. (2019) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2019.18101191 · Cited by 344
Antipsychotic Treatment and Functional Connectivity of the Striatum in First-Episode Schizophrenia
Sarpal, D. K., Robinson, D. G., Lencz, T., Árgyelán, M., Ikuta, T., Karlsgodt, K. H., Gallego, J. A., Kane, J. M., Szeszko, P. R., & Malhotra, A. K. (2014) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.1734 · Cited by 328
Continued versus discontinued cannabis use in patients with psychosis: a systematic review and meta-analysis
Schoeler, T., Monk, A., Sami, M. B., Klamerus, E., Foglia, E., Brown, R., Camuri, G., Altamura, A. C., Murray, R., & Bhattacharyya, S. (2016) · The Lancet Psychiatry · doi:10.1016/s2215-0366(15)00363-6 · Cited by 322
Self-citation
Gone to Pot – A Review of the Association between Cannabis and Psychosis
Radhakrishnan, R., Wilkinson, S. T., & Dâ€TMSouza, D. C. (2014) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2014.00054 · Cited by 327
Effects of Cannabis on Neurocognitive Functioning: Recent Advances, Neurodevelopmental Influences, and Sex Differences
Crane, N. A., Schuster, R. M., Fusar‐Poli, P., & González, R. (2012) · Neuropsychology Review · doi:10.1007/s11065-012-9222-1 · Cited by 330
Translational investigation of the therapeutic potential of Cannabidiol (CBD): Toward a new age
Crippa, J. A., Guimarães, F. S., Campos, A. C., & Zuardi, A. W. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02009 · Cited by 308
A systematic review of the antipsychotic properties of cannabidiol in humans
Iseger, T. A., & Bossong, M. G. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2015.01.033 · Cited by 261
Involvement of the dorsal and ventral attention networks in oddball stimulus processing: A meta‐analysis
Kim, H. (2013) · Human Brain Mapping · doi:10.1002/hbm.22326 · Cited by 248
The neuropsychopharmacology of cannabis: A review of human imaging studies
Bloomfield, M., Hindocha, C., Green, S. F., Wall, M. B., Lees, R., Petrilli, K., Costello, H., Ogunbiyi, O., Bossong, M. G., & Freeman, T. P. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.10.006 · Cited by 247
A critical review of the antipsychotic effects of cannabidiol: 30 years of a translational investigation
Waldo Zuardi, A., Alexandre S. Crippa, J., E.C. Hallak, J., Bhattacharyya, S., Atakan, Z., Martin-Santos, R., K. McGuire, P., & Silveira Guimaraes, F. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212802884681 · Cited by 222
Self-citation
Cannabis and the Developing Brain: Insights into Its Long-Lasting Effects
Hurd, Y. L., Manzoni, O. J., Pletnikov, M. V., Lee, F. S., Bhattacharyya, S., & Melis, M. (2019) · The Journal of Neuroscience · doi:10.1523/jneurosci.1165-19.2019 · Cited by 218
Self-citation
Cannabis-associated psychosis: Neural substrate and clinical impact
Murray, R. M., Englund, A., Abi‐Dargham, A., Lewis, D. A., Forti, M. D., Davies, C., Sherif, M. A., McGuire, P. K., & D’Souza, D. C. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.06.018 · Cited by 210
Synthetic and Non-synthetic Cannabinoid Drugs and Their Adverse Effects-A Review From Public Health Prospective
Cohen, K., & Weinstein, A. M. (2018) · Frontiers in Public Health · doi:10.3389/fpubh.2018.00162 · Cited by 209
The Neural Substrate of Reward Anticipation in Health: A Meta-Analysis of fMRI Findings in the Monetary Incentive Delay Task
MTAC, Wilson, R. P., Colizzi, M., Bossong, M. G., Allen, P., Kempton, M. J., & Bhattacharyya, S. (2018) · Neuropsychology Review · doi:10.1007/s11065-018-9385-5 · Cited by 196
Self-citation
Analysis of Cannabis Seizures in NSW, Australia: Cannabis Potency and Cannabinoid Profile
Swift, W., Wong, A. C. H., Li, K. M., Arnold, J. C., & McGregor, I. S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070052 · Cited by 185
Cannabidiol (CBD) use in psychiatric disorders: A systematic review
Bonaccorso, S., Ricciardi, A., Zangani, C., Chiappini, S., & Schifano, F. (2019) · NeuroToxicology · doi:10.1016/j.neuro.2019.08.002 · Cited by 180
Altered Striatal Functional Connectivity in Subjects With an At-Risk Mental State for Psychosis
Dandash, O., Fornito, A., Lee, J., Keefe, R. S. E., Chee, M. W. L., Adcock, R. A., Pantelis, C., Wood, S. J., & Harrison, B. J. (2013) · Schizophrenia Bulletin · doi:10.1093/schbul/sbt093 · Cited by 165
Effects of continuation, frequency, and type of cannabis use on relapse in the first 2 years after onset of psychosis: an observational study
Schoeler, T., Petros, N., Forti, M. D., Klamerus, E., Foglia, E., Ajnakina, O., Gayer-Anderson, C. E., Colizzi, M., Quattrone, D., Behlke, I., et al. (2016) · The Lancet Psychiatry · doi:10.1016/s2215-0366(16)30188-2 · Cited by 162
Self-citation
Effect of Cannabidiol on Medial Temporal, Midbrain, and Striatal Dysfunction in People at Clinical High Risk of Psychosis: A Randomized Clinical Trial
Bhattacharyya, S., Wilson, R., Appiah-Kusi, E., O'Neill, A., Brammer, M., Perez, J., Murray, R., Allen, P., Bossong, M., & McGuire, P. (2018) · JAMA psychiatry · doi:10.1001/jamapsychiatry.2018.2309 · Cited by 134
Self-citation
Therapeutic potential of cannabis-related drugs
Alexander, S. P. H. (2016) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2015.07.001 · Cited by 149
Effect of cannabis on glutamate signalling in the brain: A systematic review of human and animal evidence
Colizzi, M., McGuire, P. K., Pertwee, R. G., & Bhattacharyya, S. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.03.010 · Cited by 146
Self-citation
Does Cannabis Composition Matter? Differential Effects of Delta-9-tetrahydrocannabinol and Cannabidiol on Human Cognition
Colizzi, M., & Bhattacharyya, S. (2017) · Current Addiction Reports · doi:10.1007/s40429-017-0142-2 · Cited by 138
Self-citation
Heavy cannabis use, dependence and the brain: a clinical perspective
Kroon, E., Kuhns, L., Hoch, E., & Cousijn, J. (2019) · Addiction · doi:10.1111/add.14776 · Cited by 133
Impact of Cannabis Use on the Development of Psychotic Disorders
Wilkinson, S. T., Radhakrishnan, R., & D’Souza, D. C. (2014) · Current Addiction Reports · doi:10.1007/s40429-014-0018-7 · Cited by 139
Human Laboratory Studies on Cannabinoids and Psychosis
Sherif, M. A., Radhakrishnan, R., D’Souza, D. C., & Ranganathan, M. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2016.01.011 · Cited by 129
Therapeutic potential of cannabinoid medicines
Robson, P. (2013) · Drug Testing and Analysis · doi:10.1002/dta.1529 · Cited by 126
Psychosis relapse during treatment with long-acting injectable antipsychotics in individuals with schizophrenia-spectrum disorders: an individual participant data meta-analysis.
Rubio, J., Schoretsanitis, G., John, M., Tiihonen, J., Taipale, H., Guinart, D., Malhotra, A., Correll, C., & Kane, J. (2020) · Lancet psychiatry · doi:10.1016/s2215-0366(20)30264-9 · Cited by 96
Cannabinoid Modulation of Functional Connectivity within Regions Processing Attentional Salience
Bhattacharyya, S., Falkenberg, I., Martín‐Santos, R., Atakan, Z., Crippa, J. A. S., Giampietro, V., Brammer, M. J., & McGuire, P. K. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.258 · Cited by 114
Self-citation
Marijuana: Current Concepts†
Greydanus, D. E., Hawver, E. K., Greydanus, M. M., & Merrick, J. (2013) · Frontiers in Public Health · doi:10.3389/fpubh.2013.00042 · Cited by 112
Cannabidiol as a potential treatment for psychosis
Davies, C., & Bhattacharyya, S. (2019) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125319881916 · Cited by 121
Self-citation
Changes in cannabis use among young people
Copeland, J., Rooke, S. E., & Swift, W. (2013) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e328361eae5 · Cited by 111
Neuropsychological Consequences of Chronic Drug Use: Relevance to Treatment Approaches
Cadet, J. L., & Bisagno, V. (2016) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2015.00189 · Cited by 110
Is cannabis neurotoxic for the healthy brain? A meta‐analytical review of structural brain alterations in non‐psychotic users
Rocchetti, M., Crescini, A., Borgwardt, S., Caverzasi, E., Politi, P., Atakan, Z., & Fusar‐Poli, P. (2013) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12085 · Cited by 109
Cannabidiol as a potential treatment for psychosis
Schubart, C. D., Sommer, I. E., Fusar‐Poli, P., de Witte, L. D., Kahn, R. S., & Boks, M. P. (2013) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2013.11.002 · Cited by 105
Cannabis use and transition to psychosis in people at ultra-high risk
Valmaggia, L., Day, F., Jones, C., Bissoli, S., Pugh, C., Hall, D., Bhattacharyya, S., Howes, O. D., Stone, J. M., Fusar‐Poli, P., et al. (2014) · Psychological Medicine · doi:10.1017/s0033291714000117 · Cited by 97
Self-citation
Neuronal and molecular effects of cannabidiol on the mesolimbic dopamine system: Implications for novel schizophrenia treatments
Renard, J., Norris, C., Rushlow, W. J., & Laviolette, S. R. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.02.006 · Cited by 99
Effects of Cannabis on Impulsivity: A Systematic Review of Neuroimaging Findings
Wrege, J. S., Schmidt, A., Walter, A., Smieskova, R., Bendfeldt, K., Radue, E. W., Lang, U. E., & Borgwardt, S. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113199990428 · Cited by 97
Effects of short-term cannabidiol treatment on response to social stress in subjects at clinical high risk of developing psychosis
Appiah‐Kusi, E., Petros, N., Wilson, R. J., Colizzi, M., Bossong, M. G., Valmaggia, L., Mondelli, V., McGuire, P. K., & Bhattacharyya, S. (2020) · Psychopharmacology · doi:10.1007/s00213-019-05442-6 · Cited by 93
Self-citation
Dissociable effects of cannabis with and without cannabidiol on the human brain’s resting-state functional connectivity
Wall, M. B., Pope, R. A., Freeman, T. P., Kowalczyk, O. S., Demetriou, L., Mokrysz, C., Hindocha, C., Lawn, W., Bloomfield, M., Freeman, A. M., et al. (2019) · Journal of Psychopharmacology · doi:10.1177/0269881119841568 · Cited by 92
Neuroimaging studies of acute effects of THC and CBD in humans and animals: a systematic review
Batalla, A., Crippa, J. A., Busatto, G. F., Guimaraes, F. S., Zuardi, A. W., Valverde, O., Atakan, Z., McGuire, P. K., Bhattacharyya, S., & Martín-Santos, R. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113199990432 · Cited by 91
Self-citation
Modulatory effects of cannabinoids on brain neurotransmission
Cohen, K., Weizman, A., & Weinstein, A. M. (2019) · European Journal of Neuroscience · doi:10.1111/ejn.14407 · Cited by 98
Residual effects of cannabis use in adolescent and adult brains — A meta-analysis of fMRI studies
Blest‐Hopley, G., Giampietro, V., & Bhattacharyya, S. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.03.008 · Cited by 93
Self-citation
Cannabidiol Counteracts the Psychotropic Side-Effects of Δ-9-Tetrahydrocannabinol in the Ventral Hippocampus through Bidirectional Control of ERK1–2 Phosphorylation
Hudson, R., Renard, J., Norris, C., Rushlow, W. J., & Laviolette, S. R. (2019) · Journal of Neuroscience · doi:10.1523/jneurosci.0708-19.2019 · Cited by 97
Is the Adolescent Brain at Greater Vulnerability to the Effects of Cannabis? A Narrative Review of the Evidence
Blest‐Hopley, G., Colizzi, M., Giampietro, V., & Bhattacharyya, S. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00859 · Cited by 92
Self-citation
Continuity of cannabis use and violent offending over the life course
Schoeler, T., Theobald, D., Pingault, J., Farrington, D. P., Jennings, W. G., Piquero, A. R., Coid, J., & Bhattacharyya, S. (2016) · Psychological Medicine · doi:10.1017/s0033291715003001 · Cited by 85
Self-citation
Neuropharmacological Effects of the Main Phytocannabinoids: A Narrative Review
SANTOS, R. G. D., Hallak, J. E. C., & Crippa, J. A. S. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-57369-0_3 · Cited by 82
Impairment of inhibitory control processing related to acute psychotomimetic effects of cannabis
Bhattacharyya, S., Atakan, Z., Martín‐Santos, R., Crippa, J. A. S., Kambeitz, J. P., Malhi, S., Giampietro, V., Williams, S., Brammer, M. J., Rubia, K., et al. (2014) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2014.11.018 · Cited by 81
Self-citation
Neuroimaging meta-analysis of cannabis use studies reveals convergent functional alterations in brain regions supporting cognitive control and reward processing
Yanes, J. A., Riedel, M. C., Ray, K. L., Kirkland, A. E., Bird, R. T., Boeving, E. R., Reid, M. A., González, R., Robinson, J. L., Laird, A. R., et al. (2018) · Journal of Psychopharmacology · doi:10.1177/0269881117744995 · Cited by 81
Normalization of mediotemporal and prefrontal activity, and mediotemporal-striatal connectivity, may underlie antipsychotic effects of cannabidiol in psychosis
O’Neill, A., Wilson, R. P., Blest‐Hopley, G., Annibale, L., Colizzi, M., Brammer, M. J., Giampietro, V., & Bhattacharyya, S. (2020) · Psychological Medicine · doi:10.1017/s0033291719003519 · Cited by 77
Self-citation
Acute and Non-acute Effects of Cannabis on Human Memory Function: A Critical Review of Neuroimaging Studies
Bossong, M. G., Jager, G., Bhattacharyya, S., & Allen, P. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113199990436 · Cited by 75
Self-citation
Cannabidiol Modulates Fear Memory Formation Through Interactions with Serotonergic Transmission in the Mesolimbic System
Norris, C., Loureiro, M., Kramar, C. P., Zunder, J. S., Renard, J., Rushlow, W. J., & Laviolette, S. R. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2016.93 · Cited by 75
Delta-9-tetrahydrocannabinol increases striatal glutamate levels in healthy individuals: implications for psychosis
Colizzi, M., Weltens, N., McGuire, P. K., Lythgoe, D. J., Williams, S., Oudenhove, L. V., & Bhattacharyya, S. (2019) · Molecular Psychiatry · doi:10.1038/s41380-019-0374-8 · Cited by 74
Self-citation
The why behind the high: determinants of neurocognition during acute cannabis exposure
Ramaekers, J. G., Mason, N. L., Kloft, L., & Theunissen, E. L. (2021) · Nature reviews. Neuroscience · doi:10.1038/s41583-021-00466-4 · Cited by 76
Acute induction of anxiety in humans by delta-9-tetrahydrocannabinol related to amygdalar cannabinoid-1 (CB1) receptors
Bhattacharyya, S., Egerton, A., Kim, E., Rosso, L., Barros, D. A. R., Hammers, A., Brammer, M. J., Turkheimer, F., Howes, O. D., & McGuire, P. K. (2017) · Scientific Reports · doi:10.1038/s41598-017-14203-4 · Cited by 73
Self-citation
Cannabis and Driving
Pearlson, G. D., Stevens, M. C., & D'Souza, D. C. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.689444 · Cited by 72
Safety and Tolerability of Cannabidiol in Parkinson Disease: An Open Label, Dose-Escalation Study
Leehey, M. A., Liu, Y., Hart, F., Epstein, C. H., Cook, M., Sillau, S., Klawitter, J., Newman, H., Sempio, C., Forman, L., et al. (2020) · Cannabis and Cannabinoid Research · doi:10.1089/can.2019.0068 · Cited by 75
The Impact of Cannabidiol on Human Brain Function: A Systematic Review
Batalla, A., Bos, J., Postma, A., & Bossong, M. G. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.618184 · Cited by 75
Cannabis Abstinence During Treatment and One-Year Follow-Up: Relationship to Neural Activity in Men
Hedy Kober, A., DeVito, E. E., DeLeone, C. M., Carroll, K. M., & Potenza, M. N. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.82 · Cited by 62
Regulation of Brain Reward by the Endocannabinoid System: A Critical Review of Behavioral Studies in Animals
Vlachou, S., & Panagis, G. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113199990433 · Cited by 62
Does cannabis affect dopaminergic signaling in the human brain? A systematic review of evidence to date
Sami, M. B., Rabiner, E. A., & Bhattacharyya, S. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.03.011 · Cited by 62
Self-citation
Probing the endocannabinoid system in healthy volunteers: Cannabidiol alters fronto-striatal resting-state connectivity
Grimm, O., Löffler, M., Kamping, S., Hartmann, A., Rohleder, C., Leweke, F. M., & Flor, H. (2018) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2018.04.004 · Cited by 62
Role of the endocannabinoid system in brain functions relevant for schizophrenia: An overview of human challenge studies with cannabis or ∆9-tetrahydrocannabinol (THC)
Bossong, M. G., Jansma, J. M., Bhattacharyya, S., & Ramsey, N. F. (2014) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2013.11.017 · Cited by 62
Self-citation
Green tea extract enhances parieto-frontal connectivity during working memory processing
Schmidt, A., Hammann, F., Wölnerhanssen, B., Meyer-Gerspach, A. C., Drewe, J., Beglinger, C., & Borgwardt, S. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3526-1 · Cited by 57
Altered orbitofrontal activity and dorsal striatal connectivity during emotion processing in dependent marijuana users after 28 days of abstinence
Zimmermann, K., Yao, S., Heinz, M., Zhou, F., Dau, W., Banger, M., Weber, B., Hurlemann, R., & Becker, B. (2017) · Psychopharmacology · doi:10.1007/s00213-017-4803-6 · Cited by 54
Cannabis affects people differently: inter-subject variation in the psychotogenic effects of Δ9-tetrahydrocannabinol: a functional magnetic resonance imaging study with healthy volunteers
Atakan, Z., Bhattacharyya, S., Allen, P., Martín‐Santos, R., Crippa, J. A. S., Borgwardt, S., Fusar‐Poli, P., Seal, M. L., Sallis, H., Stahl, D. R., et al. (2012) · Psychological Medicine · doi:10.1017/s0033291712001924 · Cited by 56
Self-citation
Effects of Cannabis Use on Human Brain Structure in Psychosis: A Systematic Review Combining In Vivo Structural Neuroimaging and Post Mortem Studies
Rapp, C., Bugra, H., Riecher‐Rössler, A., Tamagni, C., & Borgwardt, S. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212802884861 · Cited by 56
Epidemiological, Neurobiological, and Genetic Clues to the Mechanisms Linking Cannabis Use to Risk for Nonaffective Psychosis
van Winkel, R., & Kuepper, R. (2014) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-032813-153631 · Cited by 56
An introduction to psychedelic neuroscience
Calvey, T., & Howells, F. M. (2018) · Progress in brain research · doi:10.1016/bs.pbr.2018.09.013 · Cited by 57
Unraveling the Intoxicating and Therapeutic Effects of Cannabis Ingredients on Psychosis and Cognition
Colizzi, M., Ruggeri, M., & Bhattacharyya, S. (2020) · Frontiers in Psychology · doi:10.3389/fpsyg.2020.00833 · Cited by 51
Self-citation
The brain effects of cannabis in healthy adolescents and in adolescents with schizophrenia: a systematic review
James, A. C., James, C., & Thwaites, T. (2013) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2013.07.012 · Cited by 55
Terminology and assessment tools of psychosis: A systematic narrative review
Seiler, N., Nguyen, T., Yung, A. R., & O'Donoghue, B. N. (2019) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12966 · Cited by 53
Abnormalities in neuroendocrine stress response in psychosis: the role of endocannabinoids
Appiah‐Kusi, E., Leyden, E., Parmar, S. R., Mondelli, V., McGuire, P. K., & Bhattacharyya, S. (2015) · Psychological Medicine · doi:10.1017/s0033291715001786 · Cited by 46
Self-citation
Are cannabis-using and non-using patients different groups? Towards understanding the neurobiology of cannabis use in psychotic disorders
Sami, M. B., & Bhattacharyya, S. (2018) · Journal of Psychopharmacology · doi:10.1177/0269881118760662 · Cited by 45
Self-citation
Neural effects of green tea extract on dorsolateral prefrontal cortex
Borgwardt, S., Hammann, F., Scheffler, K., Kreuter, M., Drewe, J., & Beglinger, C. (2012) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2012.105 · Cited by 43
Cannabidiol (CBD) as a novel treatment in the early phases of psychosis
Chesney, E., Oliver, D., & McGuire, P. (2022) · Psychopharmacology · doi:10.1007/s00213-021-05905-9 · Cited by 40
Cannabis induced psychosis: A systematic review on the role of genetic polymorphisms
Carvalho, A. C., & Vieira‐Coelho, M. A. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106258 · Cited by 42
Dopamine modulates processing speed in the human mesolimbic system
Eckart, C., & Bunzeck, N. (2012) · NeuroImage · doi:10.1016/j.neuroimage.2012.11.001 · Cited by 38
fMRI study of cannabidiol-induced changes in attention control in treatment-resistant epilepsy
Allendorfer, J. B., Nenert, R. E., Bebin, E. M., Gaston, T. E., Grayson, L. E., Hernando, K. A., Houston, J. T., Hansen, B., & Szaflarski, J. P. (2019) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2019.04.008 · Cited by 39
The effects of acute cannabidiol on cerebral blood flow and its relationship to memory: An arterial spin labelling magnetic resonance imaging study
Bloomfield, M., Green, S. F., Hindocha, C., Yamamori, Y., Yim, J. L., Jones, A., Walker, H. R., Tokarczuk, P. F., Statton, B. K., Howes, O. D., et al. (2020) · Journal of Psychopharmacology · doi:10.1177/0269881120936419 · Cited by 42
Cannabis and psychosis: Have we found the missing links?
Parakh, P., & Basu, D. (2013) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2013.03.012 · Cited by 41
Phytocannabinoids modulate emotional memory processing through interactions with the ventral hippocampus and mesolimbic dopamine system: implications for neuropsychiatric pathology
Hudson, R., Rushlow, W. J., & Laviolette, S. R. (2017) · Psychopharmacology · doi:10.1007/s00213-017-4766-7 · Cited by 40
Protein kinase B (AKT1) genotype mediates sensitivity to cannabis-induced impairments in psychomotor control
Bhattacharyya, S., Iyegbe, C. O., Atakan, Z., Martín‐Santos, R., Crippa, J. A. S., Xu, X., Williams, S., Brammer, M. J., Rubia, K., Prata, D. P., et al. (2014) · Psychological Medicine · doi:10.1017/s0033291714000920 · Cited by 38
Self-citation
A single dose of cannabidiol modulates medial temporal and striatal function during fear processing in people at clinical high risk for psychosis
Davies, C., Wilson, R. P., Appiah‐Kusi, E., Blest‐Hopley, G., Brammer, M. J., Pérez, J., Murray, R. M., Allen, P., Bossong, M. G., McGuire, P. K., et al. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-0862-2 · Cited by 40
Self-citation
Cannabidiol modulation of hippocampal glutamate in early psychosis
O’Neill, A., Annibale, L., Blest‐Hopley, G., Wilson, R. P., Giampietro, V., & Bhattacharyya, S. (2021) · Journal of Psychopharmacology · doi:10.1177/02698811211001107 · Cited by 37
Self-citation
The Cannabis Pathway to Non-Affective Psychosis may Reflect Less Neurobiological Vulnerability
Løberg, E., Helle, S., Nygård, M., Berle, J. Ø., Kroken, R. A., & Johnsen, E. (2014) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2014.00159 · Cited by 40
Modulation of brain structure by catechol‐ O ‐methyltransferase Val158Met polymorphism in chronic cannabis users
Batalla, A., Soriano‐Mas, C., López‐Solà, M., Torrens, M., Crippa, J. A., Bhattacharyya, S., Blanco‐Hinojo, L., Fagundo, A. B., Harrison, B. J., Nogué, S., et al. (2013) · Addiction Biology · doi:10.1111/adb.12027 · Cited by 37
Self-citation
Cannabinoids and Vanilloids in Schizophrenia: Neurophysiological Evidence and Directions for Basic Research
Ruggiero, R. N., Rossignoli, M. T., Ross, J. B. D., Hallak, J. E. C., Leite, J. P., & Bueno-Júnior, L. S. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00399 · Cited by 39
The effects of cannabis use on salience attribution: a systematic review
Wijayendran, S. B., O’Neill, A., & Bhattacharyya, S. (2016) · Acta Neuropsychiatrica · doi:10.1017/neu.2016.58 · Cited by 36
Self-citation
Brain Mapping-Based Model of Δ9-Tetrahydrocannabinol Effects on Connectivity in the Pain Matrix
Walter, C., Oertel, B. G., Felden, L., Kell, C. A., Nöth, U., Vermehren, J., Kaiser, J., Deichmann, R., & Lötsch, J. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.336 · Cited by 34
Acute effects of smoked marijuana in marijuana smokers at clinical high-risk for psychosis: A preliminary study
Vadhan, N. P., Corcoran, C. M., Bedi, G., Keilp, J. G., & Haney, M. (2017) · Psychiatry Research · doi:10.1016/j.psychres.2017.07.070 · Cited by 34
A Systematic Review of Human Neuroimaging Evidence of Memory-Related Functional Alterations Associated with Cannabis Use Complemented with Preclinical and Human Evidence of Memory Performance Alterations
Blest‐Hopley, G., Giampietro, V., & Bhattacharyya, S. (2020) · Brain Sciences · doi:10.3390/brainsci10020102 · Cited by 38
Self-citation
Cannabinoids, reward processing, and psychosis
Gunasekera, B., Diederen, K. M. J., & Bhattacharyya, S. (2021) · Psychopharmacology · doi:10.1007/s00213-021-05801-2 · Cited by 35
Self-citation
Dose–response effect between cannabis use and psychosis liability in a non-clinical population: Evidence from a snowball sample
Ruíz-Veguilla, M., Barrigón, M. L., Hernández, L., Rubio, J. L., Gurpegui, M., Sarramea, F., Cervilla, J. A., Gutiérrez, B., James, A. C., & Ferrín, M. (2013) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2013.03.003 · Cited by 38
Cannabinoid Modulation of Frontolimbic Activation and Connectivity During Volitional Regulation of Negative Affect
Gorka, S. M., Phan, K. L., Lyons, M., Mori, S., Angstadt, M., & Rabinak, C. A. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.359 · Cited by 35
Preclinical and Clinical Evidence Supporting Use of Cannabidiol in Psychiatry
Calapai, G., Mannucci, C., Chinou, İ., Cardia, L., Calapai, F., Sorbara, E. E., Firenzuoli, B., Ricca, V., Gensini, G. F., & Firenzuoli, F. (2019) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2019/2509129 · Cited by 36
Neuroimaging studies towards understanding the central effects of pharmacological cannabis products on patients with epilepsy
Allendorfer, J. B., & Szaflarski, J. P. (2017) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2016.11.020 · Cited by 32
Dopamine Controls the Neural Dynamics of Memory Signals and Retrieval Accuracy
Apitz, T., & Bunzeck, N. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.141 · Cited by 30

Authors: Bhattacharyya, S.
Affiliations: King's College London (GB)
Corresponding author: Bhattacharyya, Sagnik
ORCID: Bhattacharyya, Sagnik
Venue: Archives of General Psychiatry
Publisher: American Medical Association (AMA)
Published: 2012-01-01
Volume: 69
Issue: 1
Pages: 27
ISSN: 0003-990X (ISSN-L)
DOI: 10.1001/archgenpsychiatry.2011.161
OpenAlex: W2158902140
Cited by: 203
References: 73
Citations by year: 2026: 5 · 2025: 5 · 2024: 12 · 2023: 7 · 2022: 8 · 2021: 19 · 2020: 18 · 2019: 18 · 2018: 16 · 2017: 20 · 2016: 11 · 2015: 10 · 2014: 20 · 2013: 20 · 2012: 14
FWCI: 15.05
Type: journal article
Language: en
Open access: closed
Locations: Archives of General Psychiatry (publishedVersion)
PubMed (publishedVersion)
Research Portal (King's College London) (submittedVersion)
Funders: National Institute for Health and Care Research (NIHR-CS-011-001)
Topics: Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
Keywords: delta-9-tetrahydrocannabinol, cannabidiol, cannabis-induced psychosis, caudate nucleus, prefrontal cortex, hippocampus, striatal function, psychotic symptoms, schizophrenia risk, response latency
MeSH terms: Adult, Attention, Cannabidiol, Corpus Striatum, Hallucinogens, Humans, Male, Psychotic Disorders, Reaction Time, Space Perception, Dronabinol, Prefrontal Cortex, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Induction of Psychosis byΔ9-Tetrahydrocannabinol Reflects Modulation of Prefrontal and Striatal Function During Attentional Salience Processing

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks